PharmaShots | Incisive News in 3 Shots

Subscribe Now

AI based

Bridge Biotherapeutics Signs an AI-Based Research Agreement with Atomwise to Expand its Pellino Inhibitor Portfolio

Bridge Biotherapeutics Signs an AI-Based Research Agreement with Atomwise to Expand its Pellino Inhibitor Portfolio

March 11, 2020

Bayer Signs a Three Year Multi Target AI-based Agreement with Exscientia to Treat Cardiovascular and Oncology Diseases

Bayer Signs a Three Year Multi Target AI-based Agreement with Exscientia to Treat Cardiovascular and Oncology Diseases

January 10, 2020

NTU SingaporeTTSH Develops AI based Smart Medical Device for Early Detection of Congestive Heart Failure

NTU SingaporeTTSH Develops AI based Smart Medical Device for Early Detection of Congestive Heart Failure

November 30, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us